The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin
Abstract
Luteolin is 3′,4′,5,7-tetrahydroxyflavone found in celery, green pepper, and perilla leaf that inhibits tumorigenesis in animal models. We examined luteolin-mediated regulation of cell cycle progression and apoptosis in the HT-29 human colon cancer cell line. Luteolin decreased DNA synthesis and viable HT-29 cell numbers in a concentration-dependent manner. It inhibited cyclin-dependent kinase (CDK)4 and CDK2 activity, resulting in G 1 arrest with a concomitant decrease of phosphorylation of retinoblastoma protein. Activities of CDK4 and CDK2 decreased within 2 h after luteolin treatment, with a 38% decrease in CDK2 activity ( P < 0.05) observed in cells treated with 40 μmol/l luteolin. Luteolin inhibited CDK2 activity in a cell-free system, suggesting that it directly inhibits CDK2. Cyclin D 1 levels decreased after luteolin treatment, although no changes in expression of cyclin A, cyclin E, CDK4, or CDK2 were detected. Luteolin also promoted G 2/M arrest at 24 h posttreatment by downregulating cyclin B 1 expression and inhibiting cell division cycle (CDC)2 activity. Luteolin promoted apoptosis with increased activation of caspases 3, 7, and 9 and enhanced poly(ADP-ribose) polymerase cleavage and decreased expression of p21 CIP1/WAF1, survivin, Mcl-1, Bcl-x L, and Mdm-2. Decreased expression of these key antiapoptotic proteins could contribute to the increase in p53-independent apoptosis that was observed in HT-29 cells. We demonstrate that luteolin promotes both cell cycle arrest and apoptosis in the HT-29 colon cancer cell line, providing insight about the mechanisms underlying its antitumorigenic activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure-antioxidant activity relationships of flavonoids and phenolic acids
Rice-Evans, C. A., Miller, N. J., & Paganga, G. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02227-9 · Cited by 9,085
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · cited 1×
“are negative regulators of CDK activity, these proteins may also act as positive regulators of cyclin D-dependent kinases (5).”
Background
Cited by
Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Lin, Y., Shi, R., Wang, X., & Shen, H.-M. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908786241050 · Cited by 1,169
Distribution and biological activities of the flavonoid luteolin
Lopez-Lazaro, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001712 · Cited by 1,106
“Numerous studies have demonstrated that luteolin can induce apoptosis in a variety of cancer cell lines [194-206]; these reports show that this effect usually requires a concentration of luteolin of 10 M or higher.”
BackgroundLuteolin, a flavonoid, as an anticancer agent: A review
Imran, M., Rauf, A., Abu-Izneid, T., Nadeem, M., Shariati, M. A., Khan, I. A., Imran, A., Orhan, I. E., Rizwan, M., Atif, M., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108612 · Cited by 931
Perspectives for Cancer Prevention With Natural Compounds
Amin, A. R. M. R., Kucuk, O., Khuri, F. R., & Shin, D. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6235 · Cited by 572
Flavonoids: A versatile source of anticancer drugs
Sharma, N., Dobhal, M., Joshi, Y., & Chahar, M. (2011) · Pharmacognosy Reviews · doi:10.4103/0973-7847.79093 · Cited by 551
Cancer Prevention With Natural Compounds
Gullett, N. P., Ruhul Amin, A. R. M., Bayraktar, S., Pezzuto, J. M., Shin, D. M., Khuri, F. R., Aggarwal, B. B., Surh, Y.-J., & Kucuk, O. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.06.014 · Cited by 485
Cytotoxicity of dietary flavonoids on different human cancer types
Sak, K. (2014) · Pharmacognosy Reviews · doi:10.4103/0973-7847.134247 · Cited by 461
Anti-carcinogenic Effects of the Flavonoid Luteolin
Seelinger, G., Merfort, I., Wölfle, U., & Schempp, C. M. (2008) · Molecules · doi:10.3390/molecules13102628 · Cited by 369
Chien, S.-Y., Wu, Y.-C., Chung, J.-G., Yang, J.-S., Lu, H.-F., Tsou, M.-F., Wood, W., Kuo, S.-J., & Chen, D.-R. (2009) · Human & Experimental Toxicology · doi:10.1177/0960327109107002 · Cited by 269
Tavsan, Z., & Kayali, H. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109004 · Cited by 190
Oleaga, C., Ciudad, C. J., Noé, V., & Izquierdo-Pulido, M. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/390385 · Cited by 25
“…ATF-2: Activating transcription factor BAN: Biological association network CA: Caffeic acid DMSO: Dimethyl sulfoxide DEPC: Diethyl pyrocarbonate ICC: Instant caffeinated coffee RT-PCR: Reverse transcription-polymerase chain reaction STAT5B: Signal transducer and activator of transcription 5B.”
Metadata
- Authors
- Lim, D. Y., Jeong, Y., Tyner, A. L., & Park, J. H. Y.
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2007-01
- Volume
- 292
- Issue
- 1
- Pages
- G66-G75
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- OpenAlex
- W2152883122
- Cited by
- 186
- References
- 5
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.